Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
03/07/2012 | EP2424877A2 Supercharged proteins for cell penetration |
03/07/2012 | EP2424875A1 Purification of immunoconjugates |
03/07/2012 | EP2424570A1 Influenza hemagglutinin compositions and uses thereof |
03/07/2012 | EP2424569A1 Anti-mesothelin immunoconjugates and uses therefor |
03/07/2012 | EP2424568A1 Cannabinoid-containing compositions and methods for their use |
03/07/2012 | EP2424549A1 Compositions and methods for treating or preventing urolithiasis and conditions associated therewith |
03/07/2012 | EP2424525A1 Formulations of cannabidiol and methods of using the same |
03/07/2012 | EP2424507A1 Compositions and methods for treating insulin resistance and diabetes mellitus |
03/07/2012 | EP2424500A1 Lipid formulation of apoptosis promoter |
03/07/2012 | EP2424499A1 Stabilized lipid formulation of apoptosis promoter |
03/07/2012 | EP2424493A1 Intimate lubrication kit |
03/07/2012 | EP2186830B1 Polyethylene glycol modified interferon alpha 2b and preparation method and applicatioins thereof |
03/07/2012 | EP2027145B1 A process for the preparation of poly-alfa-glutamic acid and derivatives thereof |
03/07/2012 | EP1715884B1 Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion |
03/07/2012 | EP1583506B1 Eye-drop vaccine containing copolymer 1 for therapeutic immunization |
03/07/2012 | EP1398346B1 Molded object having high pullulan content, process for producing the same |
03/07/2012 | CN102369282A Nucleic acid complex and nucleic acid-delivering composition |
03/07/2012 | CN102369253A Oil gelling agent, composition containing oil gelling agent, and external preparation or cosmetic for skin |
03/07/2012 | CN102369242A Polyion complex comprising hydrophobized polyamino acid and use of same |
03/07/2012 | CN102369210A Antibiotic peptides |
03/07/2012 | CN102369023A Oligosaccharide-protein conjugates |
03/07/2012 | CN102369022A Hard capsule |
03/07/2012 | CN102369019A Fast-acting insulin formulation |
03/07/2012 | CN102369009A Co-crystal of etravirine and nicotinamide |
03/07/2012 | CN102369008A Liposome composition |
03/07/2012 | CN102369004A Treatment of psoriasis |
03/07/2012 | CN102368998A Methods of reducing the proliferation and viability of microbial agents |
03/07/2012 | CN102367291A Mono-functional group-containing multilevel branched polyethylene glycol and its synthesis method |
03/07/2012 | CN102367290A Chain-functionalized multi-level branched polyethylene glycol and synthesis method thereof |
03/07/2012 | CN102367277A Polymer conjugates of mutated neublastin |
03/07/2012 | CN102366630A Polysaccharide-staphylococcal surface adhesion carrier protein conjugates for immunization against nosocomial infections |
03/07/2012 | CN102366628A Quality stabilization technique of antitumor protein medicines |
03/07/2012 | CN102366627A Protein sensitizer of tumor chemotherapeutics |
03/07/2012 | CN102366444A Cooling patch and preparation method thereof |
03/07/2012 | CN102366442A Improved essential balm |
03/07/2012 | CN102366437A Compound dexamethasone ointment and preparation method thereof |
03/07/2012 | CN102366415A Mice lavage praziquantel suspension and preparation method thereof |
03/07/2012 | CN102366412A Preparation method of tolvaptan tablet |
03/07/2012 | CN102366411A Dexamethasone palmitate acid liposome injection |
03/07/2012 | CN102366410A Argatroban liposome injection |
03/07/2012 | CN102366409A Nizatidine liposome solid preparation |
03/07/2012 | CN102366408A Monosialotetrahexosyl ganglioside sodium liposome injection |
03/07/2012 | CN102366407A Clindamycin palmitate hydrochloride liposome solid preparation |
03/07/2012 | CN102366406A Salmeterol/fluticasone aerosol preparation with hydrofluoroalkane as propellent |
03/07/2012 | CN102366405A Fluticasone propionate aerosol preparation with hydrofluoroalkane as propellant |
03/07/2012 | CN102366404A Propofol medium-long-chain fatty emulsion |
03/07/2012 | CN102366403A Colchicine microemulsion transdermal agent, preparation method thereof and application thereof |
03/07/2012 | CN102366400A Betahistine hydrochloride injection and its production technology |
03/07/2012 | CN102366399A Procaine hydrochloride injection and its production technology |
03/07/2012 | CN102366398A Multifunctional eye drops |
03/07/2012 | CN102038764B Qingpeng powder or granules for stopping pain and diminishing swelling and preparation method thereof |
03/07/2012 | CN102008714B Ointment for promoting rapid healing of scabby chilblain |
03/07/2012 | CN101933906B Preparation method of controlled-release drug-carried composite microsphere with small particle size and high mechanical strength |
03/07/2012 | CN101919866B Method for inhibiting content decrease of Vit D2 after sterilization |
03/07/2012 | CN101912361B Cefotiam hydrochloride/anhydrous sodium carbonate medicinal composition suspension injection and new use thereof |
03/07/2012 | CN101874781B Lyophobic and modified glucan-modified long circulating liposome and preparation method thereof |
03/07/2012 | CN101864065B Biodegradable amphiphilic block copolymer containing cyclic ether side group and preparation method and applications thereof |
03/07/2012 | CN101816627B Synergistic treatment type multi-material sustained-release eye drop and preparation method |
03/07/2012 | CN101716331B Method for embedding protein biological macromolecules by using amylopectin-p-nitrocinnamic acid graft in situ |
03/07/2012 | CN101716148B Tirofiban hydrochloride freeze-dried powder injection preparation and preparation method thereof |
03/07/2012 | CN101628019B Seabuckthorn oil-polylactide-coglycolide copolymer microspheres and preparation method thereof |
03/07/2012 | CN101580239B Glycosyl biforate carbon material and preparation method and application thereof |
03/07/2012 | CN101543472B Method for preparing oxaliplatin sustained release suppository |
03/07/2012 | CN101536979B Edaravone lipid microsphere formulation and preparation method |
03/07/2012 | CN101426530B Wound healing polymer compositions and methods for use thereof |
03/07/2012 | CN101374504B Zaltoprofen-containing sustained release tablet and process for the preparation thereof |
03/07/2012 | CN101343421B Preparation method for pH controlled releasedynamic polymer packaging system |
03/07/2012 | CN101322719B Arsenic trioxide solid lipid nano granule and formulation |
03/07/2012 | CN101084993B Medicinal composition containing dalbergia and storax, preparation method and preparation |
03/07/2012 | CA2714253A1 Directed radiotherapy |
03/06/2012 | US8129552 for transporting drugs or as gene transport vehicles, as solubilizers for drugs of low solubility in water, and themselves as active ingredients against diseases such as cancer or leishmaniosis; (Z)-6-octadecenyl-1-phospho-N,N,N-trimethylpropylammonium |
03/06/2012 | US8129431 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
03/06/2012 | US8129408 Pharmaceutical composition for piperidinoalkanol compounds |
03/06/2012 | US8129360 Administration of an agent produced from phosphatidylserine (PS), lyso-phosphatidylserine or/and a physiologically acceptable salt thereof in combination with additive selected from a group comprising antioxidants, essential fatty acids, mineral substances, amino acids, mood-lifters, phospholipids |
03/06/2012 | US8129351 for treatment of atopic conditions (dermatitis, allergies) and influenza virus; point mutations |
03/06/2012 | US8129333 Antigen delivery vectors and constructs |
03/06/2012 | US8129330 Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
03/06/2012 | US8128964 Transdermal pharmaceutical delivery composition |
03/06/2012 | US8128959 Polymeric pharmaceutical agent for treatment of cancer and method for production of the same |
03/06/2012 | US8128956 Hard shell including a mixture of soluble and insoluble fiber completely surrounding an inner component which includes a lubricant such as petrolatum or mineral oil to form one dual textured pet food product |
03/06/2012 | US8128955 Food compositions containing creatine |
03/06/2012 | US8128954 Biodegradable drug-polymer delivery system |
03/06/2012 | US8128945 Drug delivery system targeting to estrogen receptor over-expressed cells |
03/06/2012 | US8128944 RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles |
03/06/2012 | US8128942 Anti-sepsis conjugate vaccine |
03/06/2012 | US8128924 Methods for using a three-dimensional stromal tissue to promote angiogenesis |
03/06/2012 | US8128912 Method of protecting skin from UV radiation using a dermatological composition having porous silicon |
03/06/2012 | CA2657491C Vaccines |
03/06/2012 | CA2540225C Solid preparation of pioglitazone, glimepiride and a polyoxyethylene sorbitan fatty acid ester |
03/06/2012 | CA2538090C Polysaccharide pseudo-sponge |
03/06/2012 | CA2534063C Aesthetic tooth coating composition comprising shellac and rosin |
03/06/2012 | CA2483707C Microparticles bearing cells and active substances |
03/06/2012 | CA2480666C Tnp-470 polymer conjugates and use thereof |
03/06/2012 | CA2465133C Low concentration of peroxide for treating or preventing vaginal infections |
03/06/2012 | CA2454592C Stable ready-to-use dosage forms containing coloring matter and active chlorine, and methods of making and using same as disinfectants |
03/06/2012 | CA2446705C Compositions of quinoxaline-based therapeutic agents and fatty acids having enhanced pharmacokinetic characteristics |
03/06/2012 | CA2446550C Abuse-resistant controlled-release opioid dosage form |
03/06/2012 | CA2445664C Use of il-18 inhibitors for treating or preventing cns injuries |
03/06/2012 | CA2434831C Polypeptide drug substances |
03/01/2012 | WO2012027696A1 Alumina nanoparticle bioconjugates and methods of stimulating an immune response using said bioconjugates |